Encompass Health: BofA Global Research raises price objective to $157 from $153
EHC•BofA Global Research raised its price objective for Encompass Health to $157 from $153.
Related News
CervoMed reports neflamapimod misses primary endpoint in Phase 2b Lewy body dementia trial
CRVO•
Wedbush raises Etsy target price to $99 from $88
ETSY•
Instacart Q3 revenue tops estimates; to be acquired by DoorDash
CART•
FuelCell Energy completes $49 million EXIM-backed financing for South Korea project
FCEL•
AGCO Q3 net income drops 83% to $50 million
AGCO•